Characteristics of Oral Manifestations in Symptomatic Non-Hospitalized COVID-19 Patients: A Cross-Sectional Study on a Sample of the Saudi Population
Zuhair S Natto,Marwah Afeef,Dalia Khalil,Dina Kutubaldin,Maryam Dehaithem,Ali Alzahrani,Heba Ashi
DOI: https://doi.org/10.2147/IJGM.S331611
IF: 2.145
2021-12-10
International Journal of General Medicine
Abstract:Zuhair S Natto, 1 Marwah Afeef, 2 Dalia Khalil, 3, 4 Dina Kutubaldin, 4 Maryam Dehaithem, 4 Ali Alzahrani, 4 Heba Ashi 1 1 Department of Dental Public Health, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia; 2 Study & Research Department, King Fahad General Hospital, Jeddah, Saudi Arabia; 3 Transformation & Planning Department, King Fahad General Hospital, Jeddah, Saudi Arabia; 4 Specialized Dental Center, King Fahad General Hospital, Jeddah, Saudi Arabia Correspondence: Zuhair S Natto Department of Dental Public Health, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia Tel +966 50 36 200 37 Email Purpose: Few case reports and letters to the editor have been published regarding oral signs and symptoms in COVID-19 patients. The aim of the study therefore is to investigate different types of oral manifestations in COVID-19 patients as well as their prevalence. Patients and Methods: The study is a cross-sectional study from a single medical center. A convenience sample was taken from all patients who were COVID-19 confirmed, symptomatic, and non-hospitalized. Demographic information, medical and travel history, general symptoms, and clinical examination results of the oral cavity were collected. Results: This study included a total of 109 patients. Loss of taste was the most common oral manifestation of COVID-19 (43.4%), followed by erythema/desquamated gingivitis and coated tongue (7.3% each) and ulcers/blisters (6.4%). Loss of taste was the only symptom persisting for 10 days. Oral manifestations appeared as a single symptom (79.3%), and dorsum of tongue was the most common oral location (72.4%). Conclusion: Loss of taste was the most prevalent specific reported oral manifestation. Other nonspecific oral lesions/symptoms are controversial. It has been suggested that oral examinations of COVID-19 patients should be conducted as part of routine examinations to investigate any possible correlation between the disease and the oral cavity. Keywords: oral cavity, loss of taste, COVID-19, symptoms, prevalence The novel coronavirus disease (COVID-19) outbreak is still a pandemic persisting after about more than one year. It has affected almost 240 million people worldwide with more than 4.8 million deaths. 1 The most commonly reported symptoms are fever, loss of taste, tiredness, and dry cough. 2–5 The majority of cases were mild (80%), and 3% maximum of cases may become serious and critically ill. The total number of recovered/discharged cases was 97%. 1 Updated research shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can infect human cells through ACE2 (angiotensin-converting enzyme 2) receptors. 6,7 This process can in turn cause an inflammatory reaction in the mucosal membrane of the tongue, salivary gland tissues, and other affected organs and tissues. 2,8 SARS-CoV-2 may also alter taste bud sensitivity. 9 Therefore, COVID-19 could contribute to several oral signs and symptoms, such as taste loss, nonspecific ulcers, blisters, desquamative gingivitis, and co-infections with fungal infections such as candida, 10,11 and few studies have been published regarding oral manifestations in specific. 12–14 However, it is still controversial whether these symptoms/signs are specific to COVID-19 disease as a result of the SARS-CoV-2 infection or as a result of other underlying conditions and consequences, such as co-infections, immune system impairment caused by the virus, or adverse effects of COVID-19 medications. 15 Moreover, the prevalence of clinical oral manifestations remains unclear. For this reason, oral manifestations of COVID-19 are a rising topic of interest in the field of oral health care, and more research with better study design is needed to clarify the association between COVID-19 and oral manifestations. Therefore, the aim of this study is to investigate the types of oral manifestations and their prevalence in patients with COVID-19 in a cross-sectional study. A cross-sectional study was conducted between July 28th and October 5th, 2020, at King Fahad General Hospital, a COVID-19 center in Jeddah, Saudi Arabia. Ethical approval was obtained from the research and studies department, Jeddah Health Affairs, Ministry of Health, and registered at King Abdulaziz City for Science and Technology (KACST) IRB # 1317. The study was conducted in accordance with the Declaration of Helsinki. Patients completed a consent form to participate in the survey and the clinical examination. A convenience sample was taken from all COVID-19 confirmed -Abstract Truncated-